Top

Published in:

Open Access 01-12-2012 | Editorial

Computational modeling and epidemiologic approaches: a new section of the journal of translational medicine

Authors: Michael N Liebman, Sabrina Molinaro

Published in: Journal of Translational Medicine | Issue 1/2012

Abstract

A new section of the Journal of Translational Medicine is being introduced to encourage rapid communication of methods and results that utilize computational modeling and epidemiologic approaches in translational medicine. The focus will be on population-based studies that extend towards more molecular level analysis. Submission of studies involving methods development is encouraged where actual application and results can be shown in the healthcare and life sciences domains.

Marincola FM: Translational Medicine: a two-way road. J Transl Med. 2003, 1: 1-10.1186/1479-5876-1-1. 24 July 2003CrossRefPubMedPubMedCentral

Liebman MN, Marincola FM: Expanding the perspective of translational medicine: the value of observational data. J Transl Med. 2012, 10: 61-10.1186/1479-5876-10-61.CrossRefPubMedPubMedCentral

Hian Chye K, Tan G: Data Mining Applications in Healthcare. J Healthc Inf Manag. 2005, 19: 2-

Shahid S: How to design next-generation EHR data models, Healthcare IT News. 2012, ,

Electronic Health Record Standards: Health Policy Brief, Health Affairs. 2010, RW Johnson Foundation, Georgetown, MD

Siciliano V, Pitino A, Gori M, Curzio O, Fortunato L, Liebman M, Molinaro S: The Application of Observational Data in Translational Medicine: Analyzing Tobacco-Use Behaviors of Adolescents. J Transl Med. 2012, 10: 89-10.1186/1479-5876-10-89. 14 May 2012CrossRefPubMedPubMedCentral

Cole BL, Fielding JE: Health Impact Assessment: A Tool to Help Policy Makers Understand Health Beyond Health Care. Annu Rev Public Health. 2007, 28: 393-412. 10.1146/annurev.publhealth.28.083006.131942.CrossRefPubMed

Liebman MN, Molinaro S: Hypothesis Generation and Evaluation in Clinical Trial Design. BIBM. 2011, 645-651. Proceedings of BIBM 2011

Nelson HD, Huffman LH, Fu R, Harris EL: U.S. Preventive Services Task Force, Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2005, 143 (5): 362-379.CrossRefPubMed

10.

Nich C, Carroll KM: ‘Intention-to-treat’ meets ‘missingdata’: implications of alternate strategies for analyzing clinical trials data. Drug Alcohol Depend. 2002, 68 (2): 121-130. 10.1016/S0376-8716(02)00111-4.CrossRefPubMedPubMedCentral

11.

Verma M, Seminara D, Fernando AJ, Christy J, Iwamoto K, Hartmuller V: Genetic and Epigenetic Biomarkers in Cancer: Improving Diagnosis, Risk Assessment, and Disease Stratification. Mol Diagn Ther. 2006, 10 (1): 1-15. 10.1007/BF03256438.CrossRefPubMed

12.

Hu H, Correll M, Kvecher L, Osmond M, Clark J, Bekhash A, Schwab G, Gao D, Gao J, Kubatin V, Shriver CD, Hooke JA, Maxwell LG, Kovatich AJ, Sheldon JG, Liebman MN, Mural RJ: DW4TR: A Data Warehouse for Translational Research. J Biomed Inform. 2011, 44: 1004-1019. 10.1016/j.jbi.2011.08.003.CrossRefPubMed

Title: Computational modeling and epidemiologic approaches: a new section of the journal of translational medicine
Authors: Michael N Liebman
Sabrina Molinaro
Publication date: 01-12-2012
Publisher: BioMed Central
Published in: Journal of Translational Medicine / Issue 1/2012
Electronic ISSN: 1479-5876
DOI: https://doi.org/10.1186/1479-5876-10-210

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2012

FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway

Enhanced antitumoral efficacy and immune response following conditionally replicative adenovirus containing constitutive HSF1 delivery to rodent tumors

Effects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1+ patients

TGF-β – an excellent servant but a bad master

Roles of microRNA on cancer cell metabolism

Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials